News Archive

Articles

October 30 2017
October 28 2017
October 28 2017
September 18 2016
September 3 2016
August 22 2016
February 15 2016
February 15 2016
February 3 2016
February 3 2016
November 4 2015
March 9 2015
March 9 2015
December 6 2014
November 19 2014
November 12 2014
September 7 2014
September 5 2014
September 5 2014
October 12 2012
January 1 2010
October 16 2009
September 24 2009
June 26 2009
February 26 2008
October 28 2006
March 6 2006
November 12 2014

Successful Clinical Trials for Prof Margaret Brimble's NNZ2566

Neuren Pharma have today released the optimistic results of the drug NNZ2566 being trialled with Rett women in the USA
The next stage is to see FDA approval for Fast Track and/or Orphan status in the first quarter of 2015.
Margaret spoke to our 2014 conference on her discovery.
She said she has always dreamt of discovering a drug that would make a difference.